Welcome to this week's Chutes & Ladders, our roundup of significant leadership hirings, firings and retirings across the ...
Rivus Pharmaceuticals’ CEO Jorge Bartolome said the biotech is on track to build a “truly differentiated” cardio metabolic ...
Meghana Keshavan covers biotech and contributes to The Readout newsletter. Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
New Taipei City, Taiwan, Sept. 18, 2025 (GLOBE NEWSWIRE) -- Jyong Biotech Ltd. (Nasdaq: MENS) (the “Company”, “Jyong Biotech”), a science-driven biotechnology company based in Taiwan committed to ...
Jyong Biotech Ltd. (Nasdaq: MENS) (the “Company” or “Jyong Biotech”), a science-driven biotechnology company dedicated to the development and commercialization of innovative plant-derived therapeutics ...
Led by former Loxo Oncology CEO Josh Bilenker, the startup now has a trio of cancer drugs in early-stage testing and more ...
REHOVOT, Israel, March 13, 2026 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. (NASDAQ/TASE: PPBT), a clinical-stage company developing next-generation cancer therapies, today announced that Gil Efron, Chief ...
"Biotechnology is now a strategic national asset," Levin writes in his book, and warns that several trends now threaten US ...
Elon Musk's SpaceX may be igniting global headlines with the company's astronomical IPO, but biotech listings saw their own ...
Ameet Mallik ('94, MBP '95) talks about his work at ADC Therapeutics and what advice he gives young people about standing out in the job market. Ameet Mallik ('94, MBP '95) is president and CEO of ADC ...
As AI transforms biology, longevity startups are attracting investors, advancing toward clinical milestones, and reshaping ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results